Johns Hopkins researchers reactivated a memory circuit in mice, causing them to seek shelter even…
Browsing: Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that is the most common cause of dementia, affecting memory, thinking, and behavior. It typically begins with mild memory loss and gradually worsens, eventually interfering with daily tasks and cognitive function. Characterized by the buildup of abnormal protein deposits—amyloid plaques and tau tangles—in the brain, Alzheimer’s is currently incurable, though research is rapidly evolving. Ongoing scientific studies are exploring its causes, early detection methods, genetic risk factors, and potential treatments, with the goal of better understanding and ultimately halting or reversing the disease.
New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction…
Researchers have captured the first images of a brain network designed to clear waste, potentially…
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s…
A new peptide inhibitor, RI-AG03, targets two key areas of the Tau protein in Alzheimer’s…
A study found that phytoene, a carotenoid, extends the lifespan of Caenorhabditis elegans and reduces…
Work could lead to the discovery of new therapeutic targets. For the first time, researchers…
Scientists researched a drug called IU1 for its potential to alleviate age-related issues in protein…
An investigation has uncovered alarming issues including increased mortality rates, absent safety records, dubious efficacy,…
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of…
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader…
A weight-maintaining hormone is essential for brain-signal transmission. New research is more closely linking obesity…
Scientists discovered a link between copper regulation and neurodegeneration, using the worm gene swip-10. Their…
Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early…
Researchers have shed new light on how amyloid-beta and tau proteins influence brain activity and…
A Rush study has found that exposure to outdoor light in the evening could be…
A study shows that rising levels of brain protein Aβ42, not the reduction of amyloid…
Researchers have identified distinct cellular pathways in aging brains that lead to Alzheimer’s, offering new…